Lansky, A., Wijns, W., Xu, B., Kelbæk, H., van Royen, N., Zheng, M., Morel, M., Knaapen, P., Slagboom, T., Johnson, T. W., Vlachojannis, G., Arkenbout, K. E., Holmvang, L., Janssens, L., Ochala, A., Brugaletta, S., Naber, C. K., Anderson, R., Rittger, H., Berti, S., Barbato, E., Toth, G. G., Maillard, L., Valina, C., Buszman, P., Thiele, H., Schächinger, V., Baumbach, A., & , (2018). targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lancet, 392(10153), 1117–1126. http://access.bl.uk/ark:/81055/vdc_100085808091.0x00004b